All Stories

  1. Cytotoxic Screening and Enhanced Anticancer Activity of Lippia alba and Clinopodium nepeta Essential Oils-Loaded Biocompatible Lipid Nanoparticles against Lung and Colon Cancer Cells
  2. Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin
  3. Editorial: Advances in green synthesis for drug discovery
  4. Enhanced anticancer activity of encapsulated geraniol into biocompatible lipid nanoparticles against A549 human lung cancer cells
  5. Bacterial Cellulose-Based Materials as Dressings for Wound Healing
  6. Quantitative determination of voriconazole by thionine reduction and its potential application in a pharmaceutical and clinical setting
  7. Pharmacological applications of nitric oxide-releasing biomaterials in human skin
  8. Pectin-based inks development for 3D bioprinting of scaffolds
  9. Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells
  10. Prodigiosin: a promising biomolecule with many potential biomedical applications
  11. Design of Nanostructured Lipid Carriers and Hybrid Lipid Nanoparticles
  12. Study of antimycobacterial, cytotoxic, and mutagenic potential of polymeric nanoparticles of copper (II) complex
  13. Microbial production and recovery of hybrid biopolymers from wastes for industrial applications- a review
  14. Patents on Violacein: A Compound with Great Diversity of Biological Activities and Industrial Potential
  15. Multi-target drug with potential applications: violacein in the spotlight
  16. Lipid, polymeric, inorganic-based drug delivery applications for platinum-based anticancer drugs
  17. Improving ciprofloxacin antimicrobial activity through lipid nanoencapsulation or non-thermal plasma on Pseudomonas aeruginosa biofilms
  18. Bacterial cellulose production using mango extracts
  19. Design of magnetic hybrid nanostructured lipid carriers containing 1,8-cineole as delivery systems for anticancer drugs: Physicochemical and cytotoxic studies
  20. Preparation, physicochemical and biopharmaceutical characterization of oxcarbazepine-loaded nanostructured lipid carriers as potential antiepileptic devices
  21. Binary Medical Nanofluids by Combination of Polymeric Eudragit Nanoparticles for Vehiculization of Tobramycin and Resveratrol: Antimicrobial, Hemotoxicity and Protein Corona Studies
  22. Silver nanoparticle filter for domestic wastewater reuse
  23. Editorial: Lipid Nanoparticles as a Novel Strategy to Deliver Bioactive Molecules
  24. Simultaneous electrochemical detection of ciprofloxacin and Ag(I) in a silver nanoparticle dissolution: Application to ecotoxicological acute studies
  25. Enzymes and biopolymers. The opportunity for the smart design of molecular delivery systems
  26. In silico and in vitro Evaluation of Mimetic Peptides as Potential Antigen Candidates for Prophylaxis of Leishmaniosis
  27. 8-Hydroxyquinoline platinum(ii) loaded nanostructured lipid carriers: synthesis, physicochemical characterization and evaluation of antitumor activity
  28. Effect of α-tocopherol on the physicochemical, antioxidant and antibacterial properties of levofloxacin loaded hybrid lipid nanocarriers
  29. Bacterial Nanocellulose in Dentistry: Perspectives and Challenges
  30. Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers
  31. Antimicrobial activities of bacterial cellulose – Silver montmorillonite nanocomposites for wound healing
  32. Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing
  33. Physiological and morphological responses of green microalgae Chlorella vulgaris to silver nanoparticles
  34. Chitosan-bacterial cellulose patch of ciprofloxacin for wound dressing: Preparation and characterization studies
  35. Assessment of in vitro cytotoxicity of imidazole ionic liquids and inclusion in targeted drug carriers containing violacein
  36. Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system
  37. Encapsulation of florfenicol by in situ crystallization into novel alginate-Eudragit RS® blended matrix for pH modulated release
  38. Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties
  39. Silybin-conjugated gold nanoparticles for antimicrobial chemotherapy against Gram-negative bacteria
  40. Development of biocarrier for violacein controlled release in the treatment of cancer
  41. Bio-inks for 3D extrusion-based bio-printed scaffolds: Printability assessment
  42. A new glioblastoma cell trap for implantation after surgical resection
  43. Formation and characterization of self-assembled bovine serum albumin nanoparticles as chrysin delivery systems
  44. Lipid nanoparticles – Metvan: revealing a novel way to deliver a vanadium compound to bone cancer cells
  45. Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment
  46. Optimization of culture conditions for kefiran production in whey: The structural and biocidal properties of the resulting polysaccharide
  47. Self-Assembly Stereo-Specific Synthesis of Silver Phosphate Microparticles on Bacterial Cellulose Membrane Surface For Antimicrobial Applications
  48. Simple colorimetric method to determine the in vitro antioxidant activity of different monoterpenes
  49. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation
  50. Development and Tailoring of Hybrid Lipid Nanocarriers
  51. Hybrid bacterial cellulose–pectin films for delivery of bioactive molecules
  52. Biopolymers from Wastes to High-Value Products in Biomedicine
  53. Novel cheese production by incorporation of sea buckthorn berries ( Hippophae rhamnoides L.) supported probiotic cells
  54. Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy
  55. Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
  56. Editorial (Thematic Issue: Targeted Therapies)
  57. Emerging Technologies for Bioactive Applications in Foods
  58. Interaction of Solid Lipid Nanoparticles and Specific Proteins of the Corona Studied by Surface Plasmon Resonance
  59. Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: physicochemical characterization and in vivo targeted delivery to the lungs
  60. A simple green route to obtain poly(vinyl alcohol) electrospun mats with improved water stability for use as potential carriers of drugs
  61. Development of Crystal Violet encapsulation in pectin - Arabic gum gel microspheres
  62. Kefiran-alginate gel microspheres for oral delivery of ciprofloxacin
  63. Advances in Chromobacterium violaceum and properties of violacein-Its main secondary metabolite: A review
  64. Progress in bacterial cellulose matrices for biotechnological applications
  65. Preparation And Characterization Of Polyvinyl Alcohol–pectin Cryogels Containing Enrofloxacin And Keratinase As Potential Transdermal Delivery Device
  66. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization
  67. Development of antimicrobial hybrid mesoporous silver phosphate–pectin microspheres for control release of levofloxacin
  68. Modified bacterial cellulose scaffolds for localized doxorubicin release in human colorectal HT-29 cells
  69. Novel technologies for the encapsulation of bioactive food compounds
  70. Construction andin vitrotesting of a cellulose dura mater graft
  71. Nanobiotechnology Solutions againstAedes aegypti
  72. Characterization of smart auto-degradative hydrogel matrix containing alginate lyase to enhance levofloxacin delivery against bacterial biofilms
  73. Milk kefir: composition, microbial cultures, biological activities, and related products
  74. Self-assembly of carrageenin-CaCO3 hybrid microparticles on bacterial cellulose films for doxorubicin sustained delivery
  75. Nanodevices for the immobilization of therapeutic enzymes
  76. Development and characterization of new enzymatic modified hybrid calcium carbonate microparticles to obtain nano-architectured surfaces for enhanced drug loading
  77. Development of biopolymer nanocomposite for silver nanoparticles and Ciprofloxacin controlled release
  78. Biocatalysis
  79. Synthesis and characterization of CaCO 3 –biopolymer hybrid nanoporous microparticles for controlled release of doxorubicin
  80. BaCarb™: anovel bioinorganic matrix for local drug delivery
  81. Encapsulation of Congo Red in carboxymethyl guar gum–alginate gel microspheres
  82. Characterization and Stability Analysis of Biopolymeric Matrices Designed for Phage-Controlled Release
  83. Encapsulation of doxorubicin & Cogo Red in a biopolymeric matrix
  84. Studies on PVA pectin cryogels containing crosslinked enzyme aggregates of keratinase
  85. Cross-linked α-l-rhamnosidase aggregates with potential application in food industry
  86. Tailoring of alginate–gelatin microspheres properties for oral Ciprofloxacin-controlled release againstPseudomonas aeruginosa
  87. Cystic fibrosis treatment with alginate lyase and ciprofloxacin
  88. Immobilized keratinase and enrofloxacin loaded on pectin PVA cryogel patches for antimicrobial treatment
  89. Nanostability
  90. Alginate Lyase and Ciprofloxacin Co-Immobilization on Biopolymeric Microspheres for Cystic Fibrosis Treatment
  91. A novel α-l-rhamnosidase with potential applications in citrus juice industry and in winemaking
  92. Bionanoparticles, a green nanochemistry approach
  93. Novel Biopolymer Matrices for Microencapsulation of Phages: Enhanced Protection Against Acidity and Protease Activity
  94. Recent trends in biocatalysis engineering
  95. Binding and Encapsulation of Doxorubicin on Smart Pectin Hydrogels for Oral Delivery
  96. Controlled Release of Sulfasalazine Release from “Smart” Pectin Gel Microspheres under Physiological Simulated Fluids
  97. Studies of Ciprofloxacin Encapsulation on Alginate/Pectin Matrixes and Its Relationship with Biodisponibility
  98. Polyvinyl Alcohol–Pectin Cryogel Films for Controlled Release of Enrofloxacin
  99. Purification of an organic solvent-tolerant lipase from Aspergillus niger MYA 135 and its application in ester synthesis
  100. Organic solvent adaptation of Gram positive bacteria: Applications and biotechnological potentials
  101. Enzymatic synthesis of banana flavour (isoamyl acetate) by Bacillus licheniformis S-86 esterase
  102. An organic-solvent-tolerant esterase from thermophilic Bacillus licheniformis S-86
  103. Emulsan–Alginate Beads for Protein Adsorption
  104. Emulsan, a tailorable biopolymer for controlled release
  105. Production and Purification of a Solvent-Resistant Esterase from Bacillus licheniformis S-86
  106. Effects of Organic Solvents on Immobilized Lipase in Pectin Microspheres
  107. Silk coatings on PLGA and alginate microspheres for protein delivery
  108. Lindane uptake and degradation by aquatic Streptomyces sp. strain M7
  109. Biosynthesis of emulsan biopolymers from agro-based feedstocks
  110. Controlled Release Biopolymers for Enhancing the Immune Response
  111. Lindane removal induction by Streptomyces sp. M7
  112. Emulsan-Alginate Microspheres as a New Vehicle for Protein Delivery
  113. Triggered release of proteins from emulsan–alginate beads
  114. Effect of hydroxylic solvents on cell growth, sporulation, and esterase production of Bacillus licheniformis S-86
  115. Emulsan quantitation by Nile red quenching fluorescence assay
  116. Isolation of four aquatic streptomycetes strains capable of growth on organochlorine pesticides
  117. Homogeneous Biocatalysis in Organic Solvents and Water-Organic Mixtures
  118. Estimation of growth inhibition by copper and cadmium in heavy metal tolerant actinomycetes
  119. Phosphatidylinositol-specific phospholipase C activity in Lactobacillus rhamnosus with capacity to translocate
  120. Phosphatidylinositol-specific phospholipase C activity inLactobacillus rhamnosuswith capacity to translocate
  121. Chromium accumulation by two Streptomyces spp. isolated from riverine sediments
  122. Properties of soluble α-chymotrypsin in neat glycerol and water
  123. Enzymatic activities of proteases dissolved in organic solvents
  124. Thermal stabilization by polyols of β-xylanase from Bacillus amyloliquefaciens
  125. Thermal stabilization by polyols ofβ-xylanase fromBacillus amyloliquefaciens
  126. Purification and characterization of a thermostable xylanase from Bacillus amyloliquefaciens
  127. Screening of heavy metal-tolerant actinomycetes isolated from the Sali River.
  128. Antimicrobial activity of flavonoids from leaves of Tagetes minuta
  129. Thermostable alkaline proteases of Bacillus licheniformis MIR 29: isolation, production and characterization
  130. Screening of xylanolytic bacteria using a colour plate method
  131. A plate technique for screening of inulin degrading microorganisms
  132. Detection of endo-xylanase activities in electrophoretic gels with congo red staining
  133. Modelling and operation of a turbidity-meter for on-line monitoring of microbial growth in fermenters
  134. Production of α-glucosidase byBacillussp. strains
  135. Antimicrobial activity determined in strains ofBacillus circulans cluster
  136. Amylolytic enzymes produced by Bacillus amyloliquefaciens MIR‐41 in batch and continuous culture
  137. Effects of pH and temperature on the continuous production of amylolytic enzymes by bacillus amyloliquefaciens MIR‐41
  138. Acid Pullulanase from Bacillus polymyxa MIR-23
  139. A spectrophotometric method for the quantitative measurement of pullulan
  140. Extracellular isoamylase produced by Bacillus circulans MIR‐137
  141. Production of antimicrobials by Bacillus subtilis MIR 15
  142. Selection of an extracellular esterase-producing microorganism
  143. Simul taneous production of alpha and beta amylases byBacillus subtilis MIR-5 in batch and continuous culture
  144. A system for the differentiation of some closely related Bacillus species
  145. Protein measurement with neocuproine reactive
  146. Effects of human transforming growth factors on topoisomerases from normal fibroblasts